Top 5 Stocks to Buy Now
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free NUS Stock Alerts

Nu Skin Enterprises (NUS) Competitors

Nu Skin Enterprises logo
$5.12 +0.12 (+2.40%)
As of 02:52 PM Eastern
Compare

NUS vs. COTY, USNA, NATR, MED, and VERU

Should you buy Nu Skin Enterprises stock or one of its competitors? MarketBeat compares Nu Skin Enterprises with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nu Skin Enterprises include Coty (COTY), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Medifast (MED), and Veru (VERU).

How does Nu Skin Enterprises compare to Coty?

Coty (NYSE:COTY) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Coty had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Coty and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 1.00 beat Coty's score of 0.65 indicating that Nu Skin Enterprises is being referred to more favorably in the news media.

Company Overall Sentiment
Coty Positive
Nu Skin Enterprises Positive

Coty has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

Nu Skin Enterprises has a net margin of 3.78% compared to Coty's net margin of -9.20%. Nu Skin Enterprises' return on equity of 7.47% beat Coty's return on equity.

Company Net Margins Return on Equity Return on Assets
Coty-9.20% 4.59% 1.47%
Nu Skin Enterprises 3.78%7.47%4.21%

Nu Skin Enterprises has lower revenue, but higher earnings than Coty. Coty is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coty$5.89B0.29-$367.90M-$0.62N/A
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.65

42.4% of Coty shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 5.9% of Coty shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Coty presently has a consensus price target of $3.70, indicating a potential upside of 89.44%. Given Coty's stronger consensus rating and higher possible upside, equities analysts clearly believe Coty is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Coty
3 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

Coty and Nu Skin Enterprises tied by winning 8 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap personal products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.38$10.76M$0.4740.94
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.65

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, USANA Health Sciences had 5 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for USANA Health Sciences and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 1.00 beat USANA Health Sciences' score of 0.23 indicating that Nu Skin Enterprises is being referred to more favorably in the news media.

Company Overall Sentiment
USANA Health Sciences Neutral
Nu Skin Enterprises Positive

USANA Health Sciences has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market.

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences0.96% 6.21% 4.50%
Nu Skin Enterprises 3.78%7.47%4.21%

Summary

Nu Skin Enterprises beats USANA Health Sciences on 9 of the 13 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 4.7%. Nature's Sunshine Products pays an annual dividend of $0.40 per share and has a dividend yield of 1.9%. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Nature's Sunshine Products pays out 36.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nu Skin Enterprises is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nu Skin Enterprises has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.65
Nature's Sunshine Products$489.79M0.75$19.52M$1.1019.00

In the previous week, Nu Skin Enterprises' average media sentiment score of 1.00 beat Nature's Sunshine Products' score of 0.46 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Nu Skin Enterprises Positive
Nature's Sunshine Products Neutral

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Nature's Sunshine Products 4.06%14.67%9.27%

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 67.46%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 9 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Medifast?

Medifast (NYSE:MED) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

95.5% of Medifast shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 3.7% of Medifast shares are owned by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Medifast has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

Medifast currently has a consensus target price of $12.00, indicating a potential upside of 13.10%. Given Medifast's higher possible upside, equities research analysts clearly believe Medifast is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Nu Skin Enterprises' average media sentiment score of 1.00 beat Medifast's score of 0.00 indicating that Nu Skin Enterprises is being referred to more favorably in the news media.

Company Overall Sentiment
Medifast Neutral
Nu Skin Enterprises Positive

Nu Skin Enterprises has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifast$385.79M0.31-$18.67M-$1.83N/A
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.65

Nu Skin Enterprises has a net margin of 3.78% compared to Medifast's net margin of -5.78%. Nu Skin Enterprises' return on equity of 7.47% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Medifast-5.78% -4.80% -3.83%
Nu Skin Enterprises 3.78%7.47%4.21%

Summary

Nu Skin Enterprises beats Medifast on 9 of the 13 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Veru?

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap personal products companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

In the previous week, Nu Skin Enterprises' average media sentiment score of 1.00 beat Veru's score of 0.00 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Nu Skin Enterprises Positive
Veru Neutral

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Veru N/A -54.72%-39.09%

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.65
Veru$16.89M2.88-$22.73M-$0.89N/A

Veru has a consensus target price of $23.00, indicating a potential upside of 659.08%. Given Veru's stronger consensus rating and higher possible upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Nu Skin Enterprises has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, Veru has a beta of -1.15, suggesting that its stock price is 215% less volatile than the broader market.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Nu Skin Enterprises beats Veru on 10 of the 15 factors compared between the two stocks.

Get Nu Skin Enterprises News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUS vs. The Competition

Export
MetricNu Skin EnterprisesCOSMETICS&TLTRS IndustryStaples SectorNYSE Exchange
Market Cap$248.58M$3.00B$16.06B$23.12B
Dividend Yield4.78%5.08%3.50%4.06%
P/E Ratio4.6531.2425.5931.02
Price / Sales0.1717.8147.0620.86
Price / Cash2.0815.2113.2218.65
Price / Book0.312.255.774.65
Net Income$160.20M-$202.95M$678.29M$1.07B
7 Day Performance1.49%-3.32%-0.79%-1.12%
1 Month Performance-13.59%0.64%1.03%0.10%
1 Year Performance-32.94%-24.96%-12.29%24.24%

Nu Skin Enterprises Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUS
Nu Skin Enterprises
3.167 of 5 stars		$5.12
+2.4%		N/A-35.0%$248.58M$1.49B4.652,800
COTY
Coty
4.3833 of 5 stars		$2.06
-0.7%		$3.70
+80.2%		-59.7%$1.82B$5.89BN/A11,636
USNA
USANA Health Sciences
2.439 of 5 stars		$19.42
-2.5%		N/A-38.1%$367.60M$925.26M41.311,570
NATR
Nature's Sunshine Products
3.5359 of 5 stars		$20.04
-2.3%		$35.00
+74.7%		+39.1%$360.67M$480.14M18.22850
MED
Medifast
1.4722 of 5 stars		$11.94
+0.4%		$12.00
+0.5%		-21.9%$132.21M$385.79MN/A870

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:NUS) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel